Hims and Hers is a hold due to slowing growth but has long-term potential to disrupt the healthcare industry.
Source Post
Should You Buy Hims Stock Today?
Apr 2, 2026
The creator discusses Hims and Hers (HIMS), noting its historical volatility and recent developments. While acknowledging a slowdown in revenue growth and past disputes with Novo Nordisk, the creator highlights the long-term opportunity for HIMS to disrupt the inconvenient healthcare industry, similar to how Tesla disrupted car sales. The company has shown an ability to gain customers and grow revenue.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.